A Post Hoc Analysis of Statin Use in Tolvaptan ADPKD Pivotal Trial
freecme000
Published on Feb 21, 2022
https://www.asn-online.org/media/podcast/CJASN/2020_04_06_CJN.08170719.mp3
PODCAST ORGINAL SOURCE - CJASN
Susan E. Shoaf, John Ouyang, Olga Sergeyeva, Alvin Estilo, Hui Li and Deborah Leung
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
00:04 -
Watch Later
00:04Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?
9 views 580 days ago -
Watch Later
00:04 -
Watch Later
00:04Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
9 views 875 days ago -
Watch Later
00:04Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
12 views 875 days ago -
Watch Later
00:04 -
Watch Later
![Substitution of oral for intravenous cyclophosphamide in membranous nephropathy]()
00:04Substitution of oral for intravenous cyclophosphamide in membranous nephropathy
12 views 875 days ago -
Watch Later
![Long-Term Outcomes and Prognostic Factors in Kidney Transplant Recipients with Polycystic Kidney Disease]()
00:04 -
Watch Later
![Real-Life Prescribing of SGLT2 Inhibitors: How to Handle the Other Medications, Including Glucose-Lowering Drugs and Diuretics]()
00:04
